MedTrace Logo

Effectiveness of Protected Environment Rooms for AML and MDS

NCT00443300 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2012-08-02

No results posted yet for this study

Summary

The goal of this clinical research study is to learn if the "protected environment" (PE) can help to prevent infections in patients aged 60 and above who are receiving what is considered low-intensity treatment for newly-diagnosed AML or high-risk MDS.

Conditions

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Gloria N. Mattiuzzi, MD · The University of Texas MD Anderson Cancer Center

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2008-01-31
Completion
2008-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00443300 on ClinicalTrials.gov